Blockchain Registration Transaction Record

NeuroOne's Breakthrough Pain System Shows Success in Treating Facial Neuralgia

NeuroOne's FDA-cleared OneRF Trigeminal Nerve Ablation System successfully treats facial pain patients at University Hospitals, marking breakthrough in chronic pain management with minimal complications.

This development represents a significant advancement in treating chronic pain conditions that affect hundreds of thousands of patients who often struggle with limited treatment options. Trigeminal neuralgia causes excruciating facial pain that can be debilitating, and current treatments often involve medications with side effects or invasive surgeries with lengthy recovery times. NeuroOne's minimally invasive approach using temperature-controlled radiofrequency ablation could provide faster relief with fewer complications, potentially reducing healthcare costs and improving quality of life for patients. The technology's expansion into other pain management areas, particularly lower back pain which affects millions globally, suggests this could be the beginning of a broader transformation in how chronic pain is treated, moving toward more precise, targeted therapies with better safety profiles.